Comments
Sanofi says MS treatment reduced relapse rate
01.06.2012. | PARIS (Reuters) - Sanofi said on Friday that a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the annualized rate of relapse by 36 percent compared with a placebo....
